| Literature DB >> 35431740 |
Shilpi Misra1, Shivani Rastogi1, Deepak Malviya1, Rachana Gupta1, Sandeep K Yadav1, Sharif Alam1.
Abstract
Background: COVID 19 pandemic caused by severe acute respiratory syndrome coronavirus -2 has proven to be the deadliest pandemic till date. Multiple covid waves have hit people hard on each part of the continent throughout the world. The second wave in India turned out to be highly infectious and virulent. Sudden surge in cases of mucormycosis after recovery of COVID surprised many clinician. Mucormycosis being a rapidly progressive and fulminant fungal infection required surgical debridement of necrotic tissue on emergency basis. The fatal combination of immunocompromised status, multisystemic involvement, and difficult airway in these patients pose numerous new challenges regarding anesthetic management. The present study was conducted to outline major concerns and the anesthetic management of patients undergoing surgical resection for rhinoorbital mucormycosis (ROM). Materials andEntities:
Keywords: Anesthetic concerns; postcovid; rhinoorbital mucormycosis
Year: 2022 PMID: 35431740 PMCID: PMC9009547 DOI: 10.4103/sja.sja_783_21
Source DB: PubMed Journal: Saudi J Anaesth
Figure 1Flow chart depicting distribution of cases
Demographic details in the study (independent Student’s t-test)
| Demographic details |
| mean±SD |
|
|---|---|---|---|
| Age | 25 | 51.64±9.6 | 0.053 (NS) |
| Hb | 9.79±0.92 | 0.044 (S) | |
| HbA1c | 10.8±1.42 | 0.022 (S) | |
| Duration of illness | 12.18±3.68 | 0.052 (NS) |
NS: statistically nonsignificant, S: statistically significant
Frequency distribution table
| Variables |
| % |
|---|---|---|
| Sex | ||
| Male | 14 | 56 |
| Female | 11 | 44 |
| Diagnosis | ||
| Sino orbital mucor | 3 | 12 |
| Sino nasal mucor | 6 | 24 |
| Right sino nasal | 6 | 24 |
| Left sino nasal | 5 | 20 |
| Sino nasal orbital | 5 | 20 |
| Surgery | ||
| B/L endoscopic debridement | 10 | 40 |
| DNE and debridement | 3 | 12 |
| ESS + orbital exenteration | 4 | 16 |
| Left nasal cavity debridement | 1 | 4 |
| Right nasal cavity debridement | 1 | 4 |
| Right medial maxillectomy | 3 | 12 |
| Left medial maxillectomy | 3 | 12 |
| Comorbidity | ||
| Pneumonitis + T2DM + O2 | 12 | 48 |
| Pneumonitis + T2DM + RA | 2 | 8 |
| T2DM | 5 | 20 |
| Bilateral pneumonitis + T2DM | 1 | 4 |
| T2DM/HT | 3 | 12 |
| Pulmonary TB + ATT-induced hepatitis | 1 | 4 |
| Steroid | ||
| Dexa 8 mg BD | 7 | 28 |
| Dexa 4 mg BD | 1 | 4 |
| Medrol 4 mg BD | 2 | 8 |
| Medrol 16 mg OD | 2 | 8 |
| Investigations | ||
| Anemia + Hypokalemia | 8 | 32 |
| Anemia + Hypoalbuminemia | 3 | 12 |
| Anemia | 13 | 52 |
| Hypoalbuminemia | 1 | 4 |
| Postoperative | ||
| O2 inhalation | 14 | 56 |
| Room air | 11 | 44 |
| Anesthesia | ||
| GA | 6 | 24 |
| MAC | 19 | 76 |
| ASA | ||
| II | 10 | 40 |
| III | 15 | 60 |
T2DM: Type 2 diabetes Mellitus, HT: hypertension, RA: Rheumatoid arthritis, O2: on oxygen inhalation by face mask/nasal prong
Pearsons’ correlation between steroid intake and HbA1c
| Variables |
|
|
|
|---|---|---|---|
| Steroid intake HbA1c | 25 | 0.039 | 0.711 |
Figure 2Correlation between steroid intake and HbA1c
Figure 3Extension of mucormycosis
Hemodynamic measurements at different time intervals
| Vitals | Mean | Range |
|
|---|---|---|---|
| HR | |||
| Baseline | 79.7 | 77.4-82.07 | 0.061 (NS) |
| Intubation | 79.8 | 77.5-82.12 | 0.063 (NS) |
| 30 min | 82.43 | 79.94-84.9 | 0.031 (S) |
| 1 h | 83.9 | 81.35-86.4 | 0.023 (S) |
| After extubation | 80.9 | 78.8-83.02 | 0.011 (S) |
| MAP | |||
| Baseline | 84 | 76-90 | 0.066 (NS) |
| Intubation | 83 | 78-94 | 0.012 (S) |
| 30 min | 86 | 77-97 | 0.033 (S) |
| 1 h | 92 | 79-98 | 0.014 (S) |
| After extubation | 87 | 80-00 | 0.017 (S) |
| SpO2 | 93.04 | 92.22-93.86 | 0.041 (S) |